Goldman Sachs’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Sell
198,681
-192,546
-49% -$1.4M ﹤0.01% 4762
2025
Q4
$2.4M Buy
391,227
+246,499
+170% +$2.66M ﹤0.01% 4409
2025
Q3
$2.67M Sell
144,728
-475,529
-77% -$7.64M ﹤0.01% 4224
2025
Q2
$8.07M Buy
620,257
+110,545
+22% +$1.31M ﹤0.01% 2959
2025
Q1
$5.4M Buy
509,712
+42,636
+9% +$677K ﹤0.01% 3275
2024
Q4
$7.93M Buy
467,076
+43,773
+10% +$824K ﹤0.01% 3014
2024
Q3
$9.82M Sell
423,303
-22,238
-5% -$476K ﹤0.01% 2752
2024
Q2
$10.8M Buy
445,541
+82,171
+23% +$2.49M ﹤0.01% 2434
2024
Q1
$12.3M Sell
363,370
-51,271
-12% -$1.82M ﹤0.01% 2298
2023
Q4
$13.1M Buy
414,641
+69,156
+20% +$1.64M ﹤0.01% 2282
2023
Q3
$8.83M Sell
345,485
-32,241
-9% -$993K ﹤0.01% 2493
2023
Q2
$10.8M Buy
377,726
+62,324
+20% +$1.7M ﹤0.01% 2368
2023
Q1
$7.56M Buy
315,402
+6,894
+2% +$124K ﹤0.01% 2678
2022
Q4
$5.23M Sell
308,508
-19,287
-6% -$336K ﹤0.01% 3129
2022
Q3
$4.86M Sell
327,795
-42,542
-11% -$714K ﹤0.01% 3160
2022
Q2
$5.83M Buy
370,337
+88,347
+31% +$1.73M ﹤0.01% 2996
2022
Q1
$7.6M Buy
281,990
+8,666
+3% +$221K ﹤0.01% 2961
2021
Q4
$10.1M Buy
273,324
+132,196
+94% +$5.39M ﹤0.01% 2749
2021
Q3
$6.74M Buy
141,128
+82,347
+140% +$3.69M ﹤0.01% 3094
2021
Q2
$1.99M Sell
58,781
-125,596
-68% -$4.25M ﹤0.01% 4210
2021
Q1
$7.62M Sell
184,377
-262,524
-59% -$15.6M ﹤0.01% 2791
2020
Q4
$19.4M Buy
446,901
+15,998
+4% +$1.08M 0.01% 1885
2020
Q3
$18.5M Buy
430,903
+351,286
+441% +$17.4M 0.01% 1797
2020
Q2
$3.72M Buy
79,617
+16,023
+25% +$552K ﹤0.01% 3009
2020
Q1
$864K Buy
63,594
+52,128
+455% +$667K ﹤0.01% 3856
2019
Q4
$125K Buy
+11,466
New +$120K ﹤0.01% 5015
2017
Q4
Sell
-1,615
Closed -$11K 6326
2017
Q3
$11K Sell
1,615
-2,270
-58% -$17.1K ﹤0.01% 6520
2017
Q2
$30K Sell
3,885
-2,541
-40% -$20.5K ﹤0.01% 6472
2017
Q1
$51K Sell
6,426
-2,036
-24% -$18.8K ﹤0.01% 6279
2016
Q4
$124K Buy
8,462
+5,224
+161% +$78.1K ﹤0.01% 6036
2016
Q3
$56K Sell
3,238
-974
-23% -$31.5K ﹤0.01% 6433
2016
Q2
$132K Buy
4,212
+1,875
+80% +$59.1K ﹤0.01% 5984
2016
Q1
$62K Buy
2,337
+895
+62% +$30.3K ﹤0.01% 6315
2015
Q4
$63K Buy
+1,442
New +$64.9K ﹤0.01% 6422
2015
Q2
Sell
-1,979
Closed -$78K 7242
2015
Q1
$78K Buy
1,979
+335
+20% +$14.7K ﹤0.01% 6532
2014
Q4
$43K Sell
1,644
-310
-16% -$9.86K ﹤0.01% 6848
2014
Q3
$211K Sell
1,954
-368
-16% -$48K ﹤0.01% 6112
2014
Q2
$281K Buy
+2,322
New +$280K ﹤0.01% 5907

Other funds holding ARCT